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Secara Kualitatif dan Kuantitatif)
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ABStRACt
Cell mediated immunity is currently thought to be involved in the pathogenesis of oral mucosal lichen planus (OMLP). 
However, literature reveals there is no large scale data of immunohistochemistry (IHC) study on these immune cell 
populations. The aim of this study was to assess and compare immune cell surface identification markers CD3, CD4, CD8, 
CD19 and CD83 between the OMLP (n=40) and non-specific inflammatory lesions (as control group) (n=10) qualitatively 
and quantitatively. Kruskal-Wallis and Mann Whitney U tests have been used to make comparison between the test and 
control group, p values of less than 0.05 was considered to be statistically significant. T cell surface markers (CD3+, 
CD4+ and CD8+), B cells (CD19+) and mature dendritic cells (CD83+) showed intense immunostaining in OMLP tissues 
with a significantly higher expression of positive cells than in the control group (p<0.05). CD3, CD4 and CD8+ve T cells 
were the predominant inflammatory cell type in OMLP rather than CD19+ B cells, supporting the role of Th1 cells in the 
pathogenesis of OMLP. CD83+ mature dendritic cells were present in the least number and were mostly localized to areas 
where there were aggregates of lymphocyte. There was a positive correlation and direct relationship between T and B 
lymphocyte subsets whereby as one subset increased, the other follows.
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ABStRAK
Imuniti selular telah diketahui umum terlibat dalam patogenesis lichen planus (OMLP). Walau bagaimanapun, sehingga 
kini tiada kajian imunohistokimia yang membentangkan pangkalan data secara besar mengenai populasi sel-sel imun 
di dalam OMLP. Matlamat kajian ini adalah untuk menganalisis dan membandingkan identiti permukaaan sel imun CD3, 
CD4, CD8, CD19 dan CD83 antara OMLP (n=40) dan kumpulan dengan inflamasi tidak spesifik sebagai kawalan (n=10) 
secara kuantitatif dan kualitatif. Ujian statistik Kruskal-Wallis dan Mann Whitney U telah digunakan untuk membuat 
perbandingan antara kumpulan kajian dan kumpulan kawalan, nilai p yang kurang daripada 0.05 dianggap nilai statistik 
yang signifikan. Kami mendapati sel yang mempunyai identiti permukaan sel T (CD3+, CD4+ dan CD8+), sel B (CD19+) 
dan sel dendritik yang matang (CD83+) menunjukkan intensiti ‘immunostaining’ yang kuat di dalam tisu OMLP iaitu sel 
yang menunjukkan ekspresi positif berbanding dengan kumpulan kawalan (p<0.05). Sel T yang positif dengan identiti 
permukaan CD3, CD4 and CD8 adalah sel inflamasi utama di dalam OMLP berbanding dengan sel B dengan identiti 
permukaan CD19+. Ini menguatkan lagi teori bahawa sel Th1 amat penting dalam patogenesis OMLP. Sel dendritik 
matang CD83+ hadir dalam jumlah yang kecil dan kebanyakannya tertumpu di kawasan sel limfosit bergumpalan. 
Terdapat kolerasi positif dan hubungan terus antara subset sel-sel limfosit T dan B, jika satu subset bertambah maka 
subset yang lain juga turut bertambah.
Kata kunci: Imunohistokimia (IHC); mukosa mulut lichen planus (OMLP); sel imun
IntRODuCtIOn
the exact aetiology and pathogenesis of OMLP remain 
unknown but it appears to be complex and multi-factorial. 
Accumulating evidence suggests there is an immunological 
component, particularly cell-mediated immunity that 
is directly involved in the pathogenesis of the OMLP. 
Many authors in the literature support the hypothesis that 
the innate immune response plays an essential role in 
triggering the cascades of exclusively th1 cell phenotypes 
which result in the chronic exacerbations of OMLP (Porter 
et al. 1997; Walsh et al. 1990; Walton et al. 1998). In 
comparison, th2 cells induce humoral immunity and there 
is relatively little evidence available to support their role 
in the pathogenesis of OMLP (Porter et al. 1997). 
 Antigen presenting cells (APCs) play an important 
role in navigating the immune response, moderating the 
antigen presentation and providing powerful signals for 
the expansion of these autoreactive t cells (Porter et 
al. 1997; Sugerman et al. 2000). Under the influence of 
th1 cytokines, chemokines and their respective receptor, 
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this promotes the recruitment of effectors t cells and 
induces the keratinocyte capase cascade and causes basal 
keratinocytes apoptosis (Khan et al. 2003; Lodi et al. 2005). 
 the aim of this study was to assess and compare 
the immune cell surface identification markers (CD3, 
CD4, CD8, CD19 and CD83) between the OMLP and non-
specific inflammatory control group qualitatively and 
quantitatively.
MAteRIALS AnD MetHODS
SAMPLe SeLeCtIOn
For both experimental (OMLP) and control (normal or 
hyperplastic oral mucosa with non-specific inflammation) 
groups cases were selected from the archives of the 
MedLab Dental Oral Pathology Diagnostic Service, 
Faculty of Dentistry, university of Otago. All cases were 
reviewed to ensure that the diagnosis were conformed 
to the histopathological criteria as defined by the WHO 
Histological typing of Cancer and Precancer of the Oral 
Mucosa (Pindborg et al. 1997) and that adequate clinical 
information was available (age, gender, past medical 
history and clinical site of the oral lesion). exclusion 
criteria were: medically compromised patients or those 
currently on medications, specimens that were associated 
with amalgam restorations or had histological evidence 
of epithelial dysplasia or ulceration. the OMLP cases 
were sub-categorised according to epithelial thickness 
(atrophic or hyperplastic) as determined histologically. 
to allow comparison of immunohistochemistry staining, 
fifty formalin-fixed paraffin-embedded (FFPe) archived 
tissue specimens were selected and divided into three 
main groups: control group (n=10) which were samples 
of normal or hyperplastic oral mucosa with non-specific 
inflammation and the experimental groups: atrophic OMLP 
(n=20) and hyperplastic OMLP (n=20). 
IMMunOHIStOCHeMIStRy
IHC was manually performed according to a conventional 
protocol. FFPe tissue sections were deparaffinised, 
treated with heat-induced antigen retrieval technique, 
quenched in endogenous peroxidase enzyme for 15 min 
duration followed by immunostained using the following 
monoclonal mouse anti-human primary antibodies: Santa 
Cruz CD8-α/O.N.66 (1:100) DAKO CD19/Le-CD19 (1:100) 
and novocastra nCL-CD83/IH4 (1:100). For both CD3/2GV6 
(1:20) and CD4/SP35 (1:20) primary antibodies, pre-diluted 
ready to use (Rtu) rabbit monoclonal antibodies, (Ventana® 
Medical Systems, Inc., uSA) were used in an automatic 
immunostainer (Ventana® Benchmark Xt, Roche Inc., 
uSA), according to the manufacturer’s recommendations. 
Positive and negative controls were used to validate the 
IHC run. Isotype controls of normal mouse IgG (sc-2025; 
Santa Cruz Biotechnology Inc., uSA) and normal rabbit 
IgG (sc-2027; Santa Cruz Biotechnology Inc., uSA) 
antibody were used and served as negative controls for 
IHC reactions. Visualization of the antigen-antibody signal 
amplification was achieved by using an indirect enzyme 
labelled method by using a streptavidin-biotin system 
(universal LSAB™2Kit/HRP, DakoCytomation, Denmark) 
and 3, 3’diaminobenzidine (DAB) as the chromogen. two 
investigators confirmed the diagnosis of the specimens and 
evaluated the results qualitatively and quantitatively.
StAtIStICAL AnALySIS
QUalItatIVe aSSeSSMeNt
the pattern, intensity and distribution of IHC staining 
of all the test and control sections were evaluated using 
a light microscope under various magnifications up to 
1000× (Leica DM DigitalMicroscope, CtR5000, Leica 
Microsystems, uSA). the staining pattern was classified as 
cellular membrane, cytoplasmic or mixed cell membrane/
cytoplasmic staining. the staining intensity was graded 
into three groups: strong and intense staining (50% or more 
of the cells stained), weak staining (less than 10% of the 
cells stained) or no staining.
QUaNtItatIVe aSSeSSMeNt
Photomicrographs of each section were taken at ×400 
magnification and viewed after fitting with a digitally 
superimposed graticule (calibrated grid measuring in total 
at 250 μm). a software package from MacBiophotonics 
(MBF) Image J for microscopy (Windows 32-bit version) 
was used to quantify cells and a specific schedule was 
followed. One thousand mononuclear immune cells in the 
fibrous connective tissue were counted for each slide. the 
total number of cells and the number of positively stained 
cells were recorded. Results were expressed as a percentage 
of the total number of immunopositive mononuclear 
immune cells per total number of mononuclear immune 
cells that were present. Immunostaining markers data was 
analysed and quantified using Kruskal-Wallis and Mann-
Whitney u tests, with SPSS software Windows version 18.0 
(SPSS Inc., Chicago, IL). A p value of less than 0.05 was 
considered statistically significant.
ReSuLtS
For the test groups, the mean age was 58 years (hyperplastic 
OMLP) and 54 years (atrophic OMLP); the youngest patient 
was 34 years and the oldest was 84 years. Most patients 
were female (3:2). A younger age distribution was seen in 
the control group (mean age 47 years, range 14 years to 67 
years) with a similar female predominance (4:1).
QUalItatIVe aNalySIS
each IHC tissue section was first evaluated for the presence 
of reaction product (positive or negative), quality of the 
staining (staining pattern, intensity and distribution of 
positive cells) and background staining within the sections. 
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All positive control tissue sections showed positive staining 
against every immune cell marker type tested (CD3+, 
CD4+, CD8+, CD19+ and CD83+) (Figures 1(a), 1(d), 1(g), 
1(j) and 1(m)) t lymphocyte cell subsets (CD3+, CD4+ 
and CD8+), B cell (CD19+) and mature dendritic cells 
(CD83+) showed intense immunostaining in OMLP with a 
higher number of positive cells than in the control group. 
All t cells (CD3+, CD4+ and CD8+) and B cells (CD19+) 
exhibited both cellular membrane and cytoplasmic staining 
although the membranous reaction was more apparent. 
Most mature dendritic cells (CD83+) showed distinct 
cytoplasmic staining even though both cell membrane 
and cytoplasm were immunostained. Distinct brown DAB 
chromogen staining was observed with each antibody 
type with intensity comparable to the positive control 
tissue. All t cell subsets (CD3+, CD4+ and CD8+) showed 
strong and intense staining in both test and control group. 
B cells (CD19+) demonstrated strong and intense staining 
in atrophic and hyperplastic OMLP. none of the CD19+ve 
B cell was stained in the control group. Mature dendritic 
cells (CD83+) in the test groups exhibited a strong and 
intense staining, however only weak staining was apparent 
in the control group.
 In both OMLP subtypes, a diffuse t cell (CD3+ and 
CD4+) infiltrate was seen in the superficial connective 
tissue and scattered within the epithelium (Figures 1(b) 
and 1(e)). A similar distribution was observed with CD8+ 
cytotoxic t cells (Figure 1(h)). two of the OMLP samples 
exhibited lymphoid follicle formation. the follicles 
stained positively for all t cell subsets (CD3+, CD4+ and 
CD8+) and were negative for B cells (CD19+) and mature 
dendritic cells (CD83+). B cells (CD19+) were only found 
localised and scattered within the cellular infiltrate in the 
superficial connective tissue (Figure 1(k)). localised 
and sparsely distributed mature dendritic cells (CD83+) 
were seen in the superficial and deeper connective tissue 
in all OMLP samples (Figure 1(n)). In the control group, 
positive reactivity for all t cell subsets (CD3+, CD4+ and 
CD8+) was seen on scattered inflammatory cells in the 
epithelium and connective tissue (Figures 1(c), 1(f) and 
1(i)). no positive B cells (CD19+) were seen in this group 
(Figure 1(l)). For mature dendritic cells (CD83+), only a 
few, scattered cells were seen in the connective tissue 
(Figure 1(o)). table 1 summarizes each immune cell type 
staining pattern, intensity and distribution between the 
control and test group. 
QUaNtItatIVe aNalySIS
CD3+ mature t cells were present in all groups, with a 
mean value of 46% in the control group and a mean value 
of 80% in the hyperplastic OMLP group. the mean value 
for both test groups (atrophic and hyperplastic OMLP) was 
in the range between 78% and 80%, indicating that CD3+ 
distribution did not differ significantly between different 
types of OMLP. Overall, the control group had the least 
CD3+mature t cells. CD4+ helper t cells were present in 
all groups with an ordinal mean value (highest to lowest) 
of 52% (atrophic OMLP), 49% (hyperplastic OMLP) and 
31% (control group). the control group had the fewest 
CD4+ cells. Fewer CD8+ cells (range 5% to 25%) were 
seen in the control group. there were 1.5 times fewer CD8+ 
cytotoxic t cells than CD4+ t cells in both the OMLP and 
the control groups. CD19+ B cells made up only a small 
percentage of the inflammatory cell population present in 
both the atrophic (3%) and hyperplastic (3%) OMLP groups 
and none was present in the control group. Of the immune 
cells assessed, CD83+ mature dendritic cells were present 
in the least number. Atrophic OMLP tissue had more CD83+ 
mature dendritic cells than the hyperplastic group and the 
control group.
 In order to determine whether the immunohistochemical 
findings were significantly different between the OMLP and 
control groups, Kruskal-Wallis analysis was performed. 
All t and B cell markers were found to be statistically 
higher in both OMLP test groups (atrophic and hyperplastic) 
compared with the control group (p<0.001). Interestingly, 
CD83+ mature dendritic cells were present in greater 
numbers (p<0.05) in both OMLP groups compared with 
the control group (table 2). to further define and assess 
the level of statistical significance across the categories of 
the tissue groups, the Mann-Whitney u (non-parametric 
test/2-independent groups) was used. It was found that 
there was no significant difference in the types of immune 
cells between atrophic OMLP and hyperplastic OMLP (table 
2). therefore, all immune cells that were assessed showed 
no significant difference in distribution in the two forms 
of OMLP. there was a difference in the number of immune 
cells expressing the surface markers CD3+, CD4+, CD8+, 
CD19+ and CD83+ between the atrophic OMLP group and 
the control group with all showing statistically significant 
p values <0.05. When comparing hyperplastic OMLP 
and the control group, there were statistically significant 
differences for only the t and B cell markers (p<0.001). 
Differences in CD83+ expression were not statistically 
significant.
 to further examine whether there was any relationship 
between the strength of linear dependence between 
variables, a bivariate correlation (Pearson correlation) 
analysis was performed (table 3). All t cell subtypes 
(CD3+, CD4+ and CD8+) and B cells (CD19+) had a positive 
correlation close to 1; showing a direct and fairly strong 
relationship between these lymphocyte subsets, whereby 
as one type increases, the other subset increases (p<0.01) 
in both OMLP groups and the control group. Interestingly, 
CD83+ mature dendritic cells had only one direct and 
positive linear relationship with CD4 helper t cells 
(p<0.05).
DISCuSSIOn
OMLP is a relatively common chronic inflammatory 
mucocutaneous disorder that affects the population 
worldwide (Scully et al. 1998). the demographic 
distribution of our study showed similarities with those 
reported previously, where most patients were middle 
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FIGuRe 1. IHC Analysis of CD3+, CD4+, CD8+, CD19+ and CD83+ for positive control, OMLP and non-specific inflammatory 
control group (DAB) ×200 and ×400 magnification
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tABLe 1. Summary of staining pattern, intensity and distribution between the control group and OMLP groups
antibody/clone All groups Control group OMLP groups
expression
CD3/2GV6
(mature t cells)
Staining pattern
Cellular membrane 
& cytoplasmic; 
predominately 
membranous staining
Intensity
Strong, intense 
staining
Distribution
Scattered in the 
epithelium and 
connective tissue
Intensity
Strong, intense 
staining
Distribution
Diffuse infiltration 
in the superficial 
connective tissue and 
scattered within the 
epithelium
CD4/SP35 
(helper t cells)
Cellular membrane 
& cytoplasmic; 
predominately 
membranous staining
Strong, intense 
staining
Scattered in the 
epithelium  and 
connective tissue
Strong, intense 
staining
Diffuse infiltration 
in the superficial 
connective tissue and 
scattered within the 
epithelium
CD8-α/ O.N.66 
(cytotoxic t cells)
Cellular membrane 
& cytoplasmic; 
predominately 
membranous staining
Strong, intense 
staining
Scattered in the 
epithelium  and  
connective tissue
Strong, intense  
staining
Diffuse infiltration 
in the superficial 
connective tissue and 
scattered within the 
epithelium
CD19/Le-CD19 
(B cells)
Cellular membrane 
staining
no staining no staining Strong, intense 
staining
Localised and 
scattered in 
the superficial  
connective tissue
nCL-CD83/IH4 
(mature dendritic 
cells)
Cellular membrane 
and cytoplasmic; 
predominately 
cytoplasmic staining 
Weak staining Scattered in the 
connective tissue
Strong,  intense 
staining
Localised  and 
scattered in  
superficial and more 
deeper connective 
tissue
tABLe 2. non-parametric test for atrophic and hyperplastic OMLP and the control group
Immune cell marker Atrophic OMLP
% (sd)
Hyperplastic OMLP 
% (sd)
Control
% (sd)
CD3+ 78 (9)a* 80 (6)a* 46 (9)
CD4+ 52 (8)a* 49 (8)a*   31 (13)
CD8+ 35 (9)a* 32 (8)a*   20 (11)
CD19+   3 (3)a*   3 (3)a* -
CD83+   2 (1)b**  2 (1)b   1 (1)
ap<0.001, bp<0.05; Kruskal-Wallis test
*p<0.001, **p<0.05; Mann-Whitney u test
tABLe 3. Pearson correlation between associated variables
Immune cell marker CD3+ CD4+ CD8+ CD19+ CD83+
CD3+              1     1*  1* 0.4*  0.2
CD4+       1*               1  0.5* 0.4*      0.3**
CD8+              1*  0.5*                 1 0.4*  0.2
CD19+  0.4*  0.4*  0.4* 1     0
CD83+           0.3    0.3**              0.2 0     1
*p<0.01, **p<0.05; Pearson correlation analysis
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aged females (female to male ratio; 3:2) (eisen 2002; 
Sugerman & Savage 2002). Most OMLP samples were 
from the buccal mucosa (about 90% of cases), a common 
site involved in OMLP. this is followed by the tongue, 
alveolar ridge and gingiva although multiple sites may be 
involved (axell & Rundquist 1987; eisen 2002; Sugerman 
& Savage 2002). 
 Current studies show strong evidence that 
immunological mechanisms are involved in the pathogenesis 
of OMLP. Most authors support the idea that immune system 
allows proliferation and activation of t lymphocytes which 
are involved in OMLP (Porter et al. 1997; Sugerman et 
al. 2002; thornhill 2001; Walsh et al. 1990). Our study 
showed that t lymphocytes (CD3+, CD4+ and CD8+), B 
lymphocytes (CD19+) and mature dendritic cells (CD83+) 
in OMLP had a significantly higher number of positive 
cells present than in the non-specific inflammatory control 
group. the present study also confirmed the dominance of 
t lymphocytes over B lymphocytes, as has been previously 
shown by other studies (Hirota et al. 1990; Jungell et al. 
1989; Walsh et al. 1990). there was a positive correlation 
and direct relationship between these t and B lymphocyte 
subsets whereby as one type increased within the infiltrate 
in OMLP, the other subset follows. A higher proportion of 
CD4+ helper t lymphocytes were seen than CD8+ cytotoxic 
t lymphocytes in both hyperplastic and atrophic OMLP 
groups. this finding is concordant with earlier studies 
(Bhan et al. 1981; Boisnic et al. 1990; Dorrego et al. 2002) 
which relate cellular distribution with disease progression. 
In early lesions there was an influx of CD4+ helper t 
lymphocytes whereas in older OMLP there was a substantial 
increase in CD8+ cytotoxic t cells which were associated 
with membrane disruption (Porter et al. 1997; Walsh et al. 
1990; Zhou et al. 2002). there was no significant difference 
in the distribution of types of immune cells between 
atrophic (erosive) and hyperplastic (reticular) OMLP 
groups. Our findings were in agreement with Charazinska-
Carewicz et al. (2008) and Rodriguez-Nunez et al. (2001) 
where no statistically significant differences were observed 
in the peripheral blood t lymphocyte subsets th1 cells in 
patients of both OMLP groups but contradicts with an earlier 
study where it was proposed that immune cell distribution 
in lichen planus correlated with the clinical form of the 
disease (al-Fouzan et al. 1996).
 In the non-specific inflammatory control group, t 
lymphocytes (CD3+, CD4+ and CD8+) and mature dendritic 
cells (CD83+) were present, but CD19+ B cells were 
absent. this suggests the possibility of t lymphocytes and 
mature dendritic cells play an important role in immune 
surveillance by monitoring the immune system for 
pathogen associated molecular patterns (PAMPs) or foreign 
substances, destroying the affected cells and coordinating 
the overall immune response (Walton et al. 1998). CD19+ 
B cells were present, but made up only a small percentage 
of the immune cell population in both OMLP groups. 
Interestingly, atrophic OMLP showed slightly more CD19+ 
B cells compared with the hyperplastic OMLP group, but 
this is not statistically significant. B cells and plasma 
cells are known to be low in numbers in OMLP lesions 
(Charazinska-Carewicz et al. 2008; Khan et al. 2003; 
Sugerman et al. 2002) and furthermore, OMLP patients do 
not have consistent serum immunoglobulin levels (Mahood 
1981), suggesting a weak correlation with B cell associated 
th2 response in OMLP (Porter et al. 1997). 
 Of the immune cells assessed, CD83+ mature dendritic 
cells were present in the least number and were mostly 
localized to areas in the connective tissue where there were 
lymphocyte aggregates, where they were thought to play 
an ongoing role in antigen presentation (Gustafson et al. 
2007). Mature dendritic cells (CD83+) had only one direct 
relationship and that was with CD4+ t helper. Atrophic 
OMLP tissue had more CD83+mature dendritic cells than 
the hyperplastic group and the control group.
COnCLuSIOn
In conclusion, CD3, CD4 and CD8+ve t cells were the 
predominant inflammatory cell type in OMLP rather than 
CD19+ B cells, supporting the role of th1 cells in the 
pathogenesis of OMLP. CD83+ mature dendritic cells were 
present in the least number and were mostly localized to 
areas where there were lymphocyte aggregates. there was 
a positive correlation and direct relationship between t and 
B lymphocyte subsets whereby as one subset increased, 
the other subset also increased.
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